Financial Architects, Inc Dexcom Inc Transaction History

Financial Architects, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$47.79 - $75.63 $477 - $756	-10 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $16,453 - $23,001	-591 Reduced 98.34%	10 $1,000
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $16,870 - $22,946	601 New	601 $71,000
Q1 2019 May 03, 2019	SELL	$28.07 - $38.18 $16,982 - $23,098	-605 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$26.99 - $37.37 $13,629 - $18,871	505 Added 505.0%	605 $72,000
Q3 2018 Oct 29, 2018	BUY	$23.35 - $36.72 $2,335 - $3,672	100 New	100 $14,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.